Federal Register of Legislation - Australian Government

Primary content

Determinations/Health as made
This instrument amends the Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2015 (PB 64 of 2015) to improve overall clarity and operation, update cross-references to other instruments and ensure consistency with current drafting practices.
Administered by: Health
Registered 29 Jan 2020
Tabling HistoryDate
Tabled HR04-Feb-2020
Tabled Senate04-Feb-2020
To be repealed 18 Aug 2020
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003
Table of contents.

Commonwealth Coat of Arms of Australia

 

National Health (Commonwealth Price) (Pharmaceutical Benefits Supplied by Approved Pharmacists) Consequential Amendments Determination 2020

We, the members constituting the Pharmaceutical Benefits Remuneration Tribunal, make the following determination.

Dated 22 January 2020

 

Deputy President
Abbeygail Beaumont


Dr Shaun Larkin


Ms Wendy Phillips

Chairperson

Member

Member

 

 

 

  

  


Contents

1............ Name............................................................................................................................. 1

2............ Commencement............................................................................................................. 1

3............ Authority....................................................................................................................... 1

4............ Schedules...................................................................................................................... 1

Schedule 1—Amendments                                                                                                                          2

Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2015 2

 


1  Name

                   This instrument is the National Health (Commonwealth Price) (Pharmaceutical Benefits Supplied by Approved Pharmacists) Consequential Amendments Determination 2020.

2  Commencement

             (1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 February 2020.

1 February 2020

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

             (2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                   This instrument is made under paragraph 98B(1)(a) of the National Health Act 1953.

4  Schedules

                   Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1Amendments

  

Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2015

1  Subsection 6(1) (paragraph (a) of the definition of dangerous drug)

Omit “Determination under paragraph 98C(1)(b) of the Act”, substitute “National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019”.

2  Subsection 6(1) (definition of standard formula preparation)

Omit “Determination under paragraph 98C(1)(b) of the National Health Act 1953”, substitute “National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019”.

3  Section 10

Repeal the section.

4  Subsection 11(2)

Omit “Determination under paragraph 98C(1)(b) of the National Health Act 1953”, substitute “National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019”.

5  Section 17 (heading)

Repeal the heading, substitute:

17  Pharmaceutical benefits that are to be supplied as complete packs

6  Section 17

Omit “of the determination under paragraph 98C(1)(b) of the Act as a pharmaceutical benefit the complete pack of which shall be supplied regardless of any lesser quantity ordered”, substitute “to the National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019 (about benefits to be supplied as complete packs)”.

7  Paragraph 23(a)

Omit “a drug that is unstable or packed sterile, mentioned in Schedule 2 to the Determination under paragraph 98C(1)(b) of the National Health Act 1953”, substitute “described in Schedule 2 to the National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019 (about unstable or sterile ingredients)”.

8  Subsection 32(1)

Repeal the subsection, substitute:

Extemporaneously‑prepared pharmaceutical benefit without standard formula preparation

             (1)  The Commonwealth price for the supply by an approved pharmacist of an extemporaneously‑prepared pharmaceutical benefit for which there is not a standard formula preparation may be worked out by the pharmacist under section 19 if the supply is made while an election by the pharmacist to work out that price in that way is in force under subsections (1A) and (1B) of this section.

          (1A)  The pharmacist may make the election in writing given to the Chief Executive Medicare.

Note:          The pharmacist may revoke the election in the same way: see subsection 33(3) of the Acts Interpretation Act 1901 (as it applies because of section 13 of the Legislation Act 2003).

          (1B)  The election is in force for the period specified in the election (which must be at least 3 months), unless it is revoked before the end of the period.

Standard formula preparation with additive

9  Subsection 32(4)

Repeal the subsection.